118380 ⎘
Ligases forming carbon-nitrogen bonds (6.3) Acid—amino-acid ligases (peptide synthases)(6.3.2)
Sub-classes:COMPOSITIONS AND METHODS FOR HETEROLOGOUS PRODUCTION OF INDIGOIDINE
#2PROTAC-CID SYSTEMS FOR USE IN MULTIPLEX GENE REGULATION
#3BIOTECHNOLOGICAL PRODUCTION OF DESFERRIOXAMINES AND ANALOGS THEREOF
#4GENETICALLY MODIFIED AZOTOBACTER VINELANDII STRAINS AND METHODS OF USING SAME
#5METHOD FOR PRODUCING DIPEPTIDE
#6NON-RIBOSOMAL PEPTIDES AND SYNTHETASES AND METHODS OF PREPARATION AND USE THEREOF
#7Generation of acyl amino acids
#8ARTIFICIAL RIBOSOMES FOR FULLY PROGRAMMABLE SYNTHESIS OF NONRIBOSOMAL PEPTIDES
#9INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#10Generation of acyl amino acids
#11Artificial ribosomes for fully programmable synthesis of nonribosomal peptides
#12Use of Rad18 inhibitors in the treatment of tumors
#13BACTERIAL CELLS WITH IMPROVED TOLERANCE TO POLYAMINES
#14Generation of acyl amino acids
#15Artificial non-ribosomal peptide synthetases
#16COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP
#17TREATMENT OF AUTOPHAGY-RELATED DISORDERS
#18Ligand-directed covalent modification of protein
#19BARD1 isoforms in lung and colorectal cancer and use thereof
#20SUBSTANCE INDUCING EXPRESSION OF PARKIN POLYPEPTIDE AND USE THEREOF
#21E1 ENZYME MUTANTS AND USES THEREOF
#22COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#23NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER
#24R-SPONDIN ANTAGONISTS AND METHODS OF TREATING CANCER ASSOCIATED WITH ABERRANT ACTIVATION OF WNT SIGNALING
#25NON-RIBOSOMAL PROTEIN SYNTHESIS PIGMENT FUSION PEPTIDES
#26CHIMERIC NON-RIBOSOMAL PEPTIDE SYNTHETASE
#27Composition for reducing senescence of cell or subject comprising smurf2 inhibitor and use thereof
#28TREATMENT OF AUTOPHAGY-RELATED DISORDERS
#29Generation of acyl amino acids
#30Biosynthetic systems producing fungal indole alkaloids
#31Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP
#32Methods of identifying and using MDM2 inhibitors
#33SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer
#34BARD1 isoforms in lung and colorectal cancer and use thereof
#35Combination anti-HIV vectors, targeting vectors, and methods of use
#36LIGAND-DIRECTED COVALENT MODIFICATION OF PROTEIN
#37METHOD FOR PRODUCING PEPTIDES
#38Modified indole-3-acetic acid-amido synthetase GH3.6 enzyme having n-acylation activity